In cancer, PEDF can directly induce apoptosis in cancer cells by upregulating pro-apoptotic factors, primarily through the FAS/FASL pathway, while also downregulating antiapoptotic proteins like the B-cell lymphoma 2 (BCL2) family of proteins, which are associated with the intrinsic pathway [72]. This evidence concerns the gene BCL2 and cancer.